Cases inefficient antiretroviral therapy for HIV-1 in children ; СЛУЧАИ НЕЭФФЕКТИВНОЙ АНТИРЕТРОВИРУСНОЙ ТЕРАПИИ ВИЧ-1 У ДЕТЕЙ

Συγγραφείς: Yu. V. Ostankova, A. V. Semenov, M. A. Churina, A. A. Totolian, Ю. В. Останкова, А. В. Семенов, М. А. Чурина, А. А. Тотолян

Πηγή: Journal Infectology; Том 9, № 2 (2017); 72-79 ; Журнал инфектологии; Том 9, № 2 (2017); 72-79 ; 2072-6732 ; 10.22625/2072-6732-2017-9-2

Θεματικοί όροι: естественные полиморфные варианты, molecular epidemiology, gene pol, protease, reverse transcriptase, antiretroviral therapy, resistance, natural polymorphisms, молекулярная эпидемиология, ген pol, протеаза, обратная транскриптаза, антиретровирусная терапия, резистентность

Περιγραφή αρχείου: application/pdf

Relation: https://journal.niidi.ru/jofin/article/view/603/541; Joint United Nations Programme on HIV/AIDS., United Nations. Global Report: UNAIDS Report on the Global AIDS epidemic: 2012. Geneva: UNAIDS; с 2012. 212 p.; Федеральный научно-методический центр по профилактике и борьбе со СПИДом ФБУН ЦНИИ Эпидемиологии Роспотребнадзора, Справка «ВИЧ-инфекция в Российской Федерации на 31 декабря 2015 г. По данным, предоставленным территориальными центрами по профилактике и борьбе со СПИД». 2015 г.; Хоффман, К. Лечение ВИЧ-инфекции 2009 / К. Хоффман, Ю.К. Рокштро. – М.: Р.Валент, 2010. – 648 с.; Joint United Nations Programme on HIV/AIDS., United Nations. Global Report: UNAIDS Report on the Global AIDS epidemic: 2013. Geneva: UNAIDS; с 2013. 198 p.; Goosby E. The President’s Emergency Plan for AIDS Relief: marshalling all tools at our disposal toward an AIDS-free generation. Health Aff (Millwood). 2012 Jul; 31(7):1593-8.; Zeng H, Chow EP, Zhao Y, Wang Y, Tang M, Li L, Tang X, Liu X, Zhong Y, Wang A, Lo YR, Zhang L. Prevention of motherto-child HIV transmission cascade in China: a systematic review and meta-analysis. Sex Transm Infect. 2016 Mar; 92(2):116-23.; UNICEF. Progress for Children: Beyond Averages – Learning from the MDGs (No. 11). 2015 June; 68 p.; UNDP (United Nations Development Programme) World leaders adopt Sustainable Development Goals. Retrieved 2015 Sep.; Об утверждении инструкции по профилактике передачи ВИЧ инфекции от матери ребенку и образца информированного согласия на проведение химиопрофилактики ВИЧ: Приказ МЗ РФ от 19.12.2003 г. №606. – 126 с.; Prendergast AJ, Klenerman P, Goulder PJ. The impact of differential antiviral immunity in children and adults. Nat Rev Immunol. 2012 Sep; 12(9):636-48.; Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F; Ghent International AIDS Society (IAS) Working Group on HIV Infection in Women and Children. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004 Oct; 364(9441):1236-43.; Tobin NH, Aldrovandi GM. Immunology of pediatric HIV infection. Immunol Rev. 2013 Jul; 254(1):143-69.; Lowenthal ED, Bakeera-Kitaka S, Marukutira T, Chapman J, Goldrath K, Ferrand RA. Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges. Lancet Infect Dis. 2014 Jul;14(7):627-39.; Lederman MM, Calabrese L, Funderburg NT, Clagett B, Medvik K, Bonilla H, Gripshover B, Salata RA, Taege A, Lisgaris M, McComsey GA, Kirchner E, Baum J, Shive C, Asaad R, Kalayjian RC, Sieg SF, Rodriguez B. Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. J. Infect. Dis. 2011 Oct; 204(8):1217-26.; Rosenblatt HM, Stanley KE, Song LY, Johnson GM, Wiznia AA, Nachman SA, Krogstad PA; Pediatric AIDS Clinical Trials Group 377 Study Team. Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection. J. Infect. Dis. 2005 Aug; 192(3):445-55.; World Health Organization, Department of Reproductive Health and Research. Male involvement in the prevention of mother-to-child transmission of HIV. Geneva: World Health Organization; c 2012. 30 p.; Cecchini DM, Zapiola I, Fernandez Giuliano S, Martinez MG, Rodriguez CG, Bouzas MB. Etravirine resistance mutations in HIV-infected pregnant women. HIV Med. 2013 Feb;14(2):125-6.; Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994 Nov; 22(22):4673-80.; Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1996 Sep; 45(RR-12):1-35.; Paraskevis D, Magiorkinis E, Magiorkinis G, Sypsa V, Paparizos V, Lazanas M, Gargalianos P, Antoniadou A, Panos G, Chrysos G, Sambatakou H, Karafoulidou A, Skoutelis A, Kordossis T, Koratzanis G, Theodoridou M, Daikos GL, Nikolopoulos G, Pybus OG, Hatzakis A; Multicentre Study on HIV Heterogeneity. Increasing prevalence of HIV-1 subtype A in Greece: estimating epidemic history and origin. J Infect Dis. 2007 Oct; 196(8):1167-76.; Manosuthi W, Thongyen S, Nilkamhang S, Manosuthi S, Sungkanuparph S. HIV-1 drug resistance-associated mutations among antiretroviral-naive Thai patients with chronic HIV-1 infection. J Med Virol. 2013; 85(2):194-9.; Sungkanuparph S, Sukasem C, Manosuthi W, Wiboonchutikul S, Piyavong B, Chantratita W. Tipranavir resistance associated mutations in protease inhibitor-na ve patients with HIV-1 subtype A/E infection. J Clin Virol. 2008 Nov; 43(3):284-6.; Davanos N, Panos G, Gogos CA, Mouzaki A. HIV-1 subtype characteristics of infected persons living in southwestern Greece. HIV AIDS (Auckl). 2015 Dec; 7:277-83.; Sutherland KA, Mbisa JL, Cane PA, Pillay D, Parry CM. Contribution of Gag and protease to variation in susceptibility to protease inhibitors between different strains of subtype B human immunodeficiency virus type 1. J Gen Virol. 2014 Jan; 95(Pt 1):190-200.; Alteri C, Artese A, Beheydt G, Santoro MM, Costa G, Parrotta L, Bertoli A, Gori C, Orchi N, Girardi E, Antinori A, Alcaro S, d’Arminio Monforte A, Theys K, Vandamme AM, Ceccherini-Silberstein F, Svicher V, Perno CF. Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a firstline lopinavir/ritonavir-containing regimen. J Antimicrob Chemother. 2013 Oct; 68(10):2205-9.; Johnson VA, Brun-V zinet F, Clotet B, G nthard HF, Kuritzkes DR, Pillay D, Schapiro JM, Richman DD. Update of the drug resistance mutations in HIV-1: December 2010. Top HIV Med. 2010 Dec; 18(5):156-63.; Казеннова, Е.В. Проблемы субтипирования ВИЧ-1 на основе анализа гена pol и способы их разрешения / Е.В. Казеннова, И.А. Лаповок, А.В. Васильев // ВИЧ-инфекция и иммуносупрессии. – 2010. – Т. 2. № 3. – С. 42–48.; Turriziani O, Russo G, Lichtner M, Stano A, Tsague G, Maida P, Vullo V, Antonelli G. Study of the genotypic resistant pattern in HIV-infected women and children from rural west Cameroon. AIDS Res Hum Retroviruses 2008 Jun; 24(6):781-5.; Казеннова, Е.В. Естественные полиморфизмы гена pol варианта ВИЧ-1 IDU-A / Е.В. Казеннова, И.А. Лаповок, В.Ю. Лага // ВИЧ-инфекция и иммуносупрессии. – 2012. – Т. 4. № 4. – С. 44–51.; Суханова, A.Л. Полиморфизм области генома, кодирующей протеазу и обратную транскриптазу, вариантов ВИЧ-1 подтипа А, распространенных на территории СНГ / A.Л. Суханова, Н.И. Рудинский, Е.В. Богословская // Молекул. биол. – 2005. – Т. 39, № 6. – С. 1063–1071.; https://journal.niidi.ru/jofin/article/view/603

Διαθεσιμότητα: https://journal.niidi.ru/jofin/article/view/603
https://doi.org/10.22625/2072-6732-2017-9-2-72-79